Together, these findings support a model in which IMP3 functions upstream of the SREBP–FASN axis as an mRNA-binding amplifier of lipogenic signaling, promoting lipid accumulation in cervical cancer cells and suggesting a tractable metabolic vulnerability. The gene discussed is IMP3; the disease is cervical carcinoma.